| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.58B | 3.43B | 3.40B | 3.96B | 4.57B | 5.06B |
| Gross Profit | 1.66B | 1.59B | 1.54B | 1.52B | 1.57B | 1.73B |
| EBITDA | 1.26B | 1.33B | 1.67B | 1.73B | 1.80B | 1.66B |
| Net Income | 646.09M | 601.52M | 585.08M | 629.28M | 744.77M | 697.79M |
Balance Sheet | ||||||
| Total Assets | 22.30B | 21.99B | 21.99B | 22.54B | 22.68B | 20.21B |
| Cash, Cash Equivalents and Short-Term Investments | 1.51B | 1.54B | 867.81M | 1.03B | 1.87B | 966.74M |
| Total Debt | 11.51B | 11.33B | 11.53B | 11.96B | 12.37B | 10.74B |
| Total Liabilities | 13.40B | 13.37B | 13.46B | 14.26B | 14.86B | 13.30B |
| Stockholders Equity | 8.46B | 8.05B | 8.05B | 7.81B | 7.33B | 6.53B |
Cash Flow | ||||||
| Free Cash Flow | 1.64B | 1.54B | 1.07B | 255.54M | -32.45M | -1.08B |
| Operating Cash Flow | 1.83B | 1.80B | 1.44B | 977.68M | 1.21B | 514.92M |
| Investing Cash Flow | -312.95M | -251.70M | -357.17M | -689.08M | -1.11B | -1.62B |
| Financing Cash Flow | -935.87M | -888.85M | -1.25B | -1.12B | 811.19M | 466.57M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | HK$3.53B | 5.34 | 6.99% | 7.95% | -6.30% | 4.49% | |
72 Outperform | HK$10.40B | 5.27 | 8.59% | 4.37% | 0.90% | 11.31% | |
71 Outperform | HK$13.25B | 8.20 | 7.72% | 6.19% | 7.14% | 3.17% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
56 Neutral | HK$1.60B | 5.86 | 6.98% | 7.75% | 4.46% | 770.51% | |
50 Neutral | HK$1.40B | 3.31 | 3.96% | ― | 1.03% | 16.29% | |
44 Neutral | HK$4.85B | -0.83 | -30.08% | ― | 0.62% | -58.08% |